India ranked second in cumulative corona19 confirmed cases, approved for emergency use of two vaccines
AstraZeneca vaccine, native company Barat Biotech vaccine
Serum Institute, AstraZeneca Vaccine Clinical Trial
[앵커]
Two domestic vaccines were approved in India, where the second most corona19 confirmed after the United States.
In Russia, which has already vaccinated 800,000 domestic vaccines, electronic vaccination certificates have been issued.
Reporter Yeojin Lee reports.
[기자]
India, with more than 10 million corona19 cumulative confirmed cases, has officially announced approval for urgent use of two vaccines.
It is the UK AstraZeneca vaccine’Coby Shield’ produced by the local vaccine company Serum Institute, and’Cobaxine’ developed by the local company Barat Biotech.
[베누고팔 소마니 박사 / 인도의약품관리국 : 세룸 인스티튜트가 생산하는 아스트라제네카 백신과 바라트 바이오테크의 백신이 긴급 사용 승인을 받았습니다.]
Serum Institute, an Indian pharmaceutical company, the world’s largest vaccine company, conducted a clinical trial of the AstraZeneca vaccine.
In addition, 50 million doses of vaccine have already been produced so that they can be distributed immediately upon approval.
Indian Prime Minister Narendra Modi wrote a congratulatory note, “Vaccine approval will be a decisive turning point in the fight against COVID-19.”
The priority vaccination target is about 300 million people, including medical staff, police, soldiers, and the elderly in their 50s or older.
Russia, which has previously started vaccinating its own production, says more than 800,000 people have been vaccinated with Sputnik V.
Russia launched a large-scale vaccination of the public in early December of last year.
In addition, people who received vaccinations in Russia have been issued electronic vaccination certificates through public service sites from the 1st.
[미하일 무라슈코 / 러시아 보건 장관 : 1월 1일부터 누구든 코로나19 백신을 접종하면 전자 증명서를 받을 수 있습니다. 공공 서비스 사이트에서 자동 발급됩니다.]
Vaccinations from countries with vaccines are gaining momentum as they accelerate their vaccination from Russia and China to India.
This is YTN Lee Yeo-jin.
[저작권자(c) YTN & YTN plus 무단전재 및 재배포 금지]